| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $42,241 | 2 | 22 |
Sells | $1,622,534 | 7 | 78 |
| Hunt Jonathan Robert | Chief Accounting Officer | 1 | $22,295 | 0 | $0 | $22,295 |
| Williamson Robert F III | director | 1 | $19,946 | 0 | $0 | $19,946 |
| Lantheus Holdings, Inc. | 10 percent owner | 0 | $0 | 2 | $357,184 | $-357,184 |
| Lantheus Alpha Therapy, LLC | 10 percent owner | 0 | $0 | 5 | $1.27M | $-1.27M |
Perspective Therapeutics, Inc., including its various operations, specializes in the comprehensive lifecycle – from development and manufacturing to sales and marketing – of radiopharmaceutical products and medical devices. These advanced solutions are designed to treat cancer and other serious malignant conditions, serving markets both within the United States and globally. A flagship product offered by the company is its CS-1 Cesium-131 brachytherapy seeds. This treatment is specifically utilized for a broad range of cancers, such as those …
Over the last 12 months, insiders at Perspective Therapeutics, Inc. have bought $42,241 and sold $1.62M worth of Perspective Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Perspective Therapeutics, Inc. have bought $19.6M and sold $1.62M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hunt Jonathan Robert (Chief Accounting Officer) — $22,295. Williamson Robert F III (director) — $19,946.
The last purchase of 11,000 shares for transaction amount of $22,295 was made by Hunt Jonathan Robert (Chief Accounting Officer) on 2025‑11‑13.
| 2026-09-04 | Sale | Lantheus Alpha Therapy, LLC | 10 percent owner | 167,149 0.2277% | $3.15 | $526,051 | -19.49% | |
| 2026-09-03 | Sale | Lantheus Alpha Therapy, LLC | 10 percent owner | 80,783 0.1089% | $3.11 | $250,896 | -19.23% | |
| 2026-09-02 | Sale | Lantheus Alpha Therapy, LLC | 10 percent owner | 42,129 0.0371% | $3.11 | $131,219 | -18.71% | |
| 2026-09-01 | Sale | Lantheus Holdings, Inc. | 10 percent owner | 35,769 0.0316% | $3.12 | $111,574 | -17.90% | |
| 2026-09-01 | Sale | Lantheus Alpha Therapy, LLC | 10 percent owner | 35,769 0.0316% | $3.12 | $111,574 | -17.90% | |
| 2026-08-31 | Sale | Lantheus Holdings, Inc. | 10 percent owner | 78,145 0.1053% | $3.14 | $245,610 | -18.67% | |
| 2026-08-31 | Sale | Lantheus Alpha Therapy, LLC | 10 percent owner | 78,145 0.1053% | $3.14 | $245,610 | -18.67% | |
| 2025-11-13 | Hunt Jonathan Robert | Chief Accounting Officer | 11,000 0.0147% | $2.03 | $22,295 | +46.38% | ||
| 2025-11-12 | Williamson Robert F III | director | 9,498 0.0123% | $2.10 | $19,946 | +42.45% | ||
| 2025-03-31 | Woods Lori A | director | 23,475 0.0317% | $2.13 | $49,999 | +53.99% | ||
| 2025-03-31 | Williamson Robert F III | director | 38,145 0.0518% | $2.14 | $81,775 | +53.99% | ||
| 2025-03-28 | Williamson Robert F III | director | 22,192 0.0339% | $2.27 | $50,376 | +48.41% | ||
| 2025-03-28 | Spoor Johan M. | Chief Executive Officer | 26,676 0.0401% | $2.24 | $59,673 | +48.41% | ||
| 2025-03-28 | Graham Juan | Chief Financial Officer | 33,333 0.0504% | $2.25 | $74,946 | +48.41% | ||
| 2024-12-04 | Spoor Johan M. | CEO | 8,000 0.0119% | $3.77 | $30,132 | -14.02% | ||
| 2024-12-04 | HENSON HEIDI | director | 25,975 0.0396% | $3.85 | $100,004 | -14.02% | ||
| 2024-11-25 | Williamson Robert F III | director | 6,266 0.0078% | $3.64 | $22,814 | -12.33% | ||
| 2024-11-25 | Spoor Johan M. | CEO | 26,500 0.0342% | $3.79 | $100,468 | -12.33% | ||
| 2024-11-25 | Hunt Jonathan Robert | Chief Financial Officer | 12,829 0.0167% | $3.82 | $48,974 | -12.33% | ||
| 2024-06-17 | Hunt Jonathan Robert | Chief Financial Officer | 1,800 0.006% | $9.81 | $17,667 | -64.80% |
| Lantheus Alpha Therapy, LLC | 10 percent owner | 11273364 9.8758% | $9.92M | 1 | 5 | +18.53% |
| Hunt Jonathan Robert | Chief Accounting Officer | 59800 0.0524% | $52,624.00 | 4 | 0 | <0.0001% |
| Williamson Robert F III | director | 9864 0.0086% | $8,680.32 | 11 | 0 | +46.65% |
| Puhlmann Markus | Chief Medical Officer | 1375425 1.2049% | $1.21M | 1 | 0 | +147.24% |
| Woods Lori A | director | 183460 0.1607% | $161,444.80 | 3 | 0 | <0.0001% |
| Spoor Johan M. | Chief Executive Officer | 59383 0.052% | $52,257.04 | 4 | 0 | <0.0001% |
| Graham Juan | Chief Financial Officer | 35354 0.031% | $31,111.52 | 1 | 0 | +48.41% |
| HENSON HEIDI | director | 25975 0.0228% | $22,858.00 | 1 | 0 | <0.0001% |
$9,837,727 | 35 | 7.68% | $94.71M | |
$1,105,104 | 34 | -11.40% | $311.25M | |
$20,867,362 | 27 | -3.90% | $467.11M | |
Perspective Therapeutics, Inc. (CATX) | $58,749,198 | 24 | 16.21% | $100.45M |
$842,771 | 15 | 6.44% | $214.28M |
| Increased Positions | 56 | +48.28% | 8M | +17.75% |
| Decreased Positions | 45 | -38.79% | 14M | -33.37% |
| New Positions | 23 | New | 3M | New |
| Sold Out Positions | 10 | Sold Out | 820,177 | Sold Out |
| Total Postitions | 127 | +9.48% | 36M | -15.63% |
| Fmr Llc | $27,930.00 | 13.53% | 10.01M | -1M | -9.84% | 2025-09-30 |
| Blackrock, Inc. | $12,183.00 | 5.9% | 4.37M | +72,426 | +1.69% | 2025-09-30 |
| Vanguard Group Inc | $9,592.00 | 4.65% | 3.44M | +163,532 | +4.99% | 2025-09-30 |
| Avidity Partners Management Lp | $8,353.00 | 4.05% | 2.99M | +1M | +61.09% | 2025-09-30 |
| Morgan Stanley | $7,703.00 | 3.73% | 2.76M | +1M | +70.07% | 2025-09-30 |
| Millennium Management Llc | $7,146.00 | 3.46% | 2.56M | -32,487 | -1.25% | 2025-09-30 |
| Nicholson Wealth Management Group, Llc | $4,515.00 | 2.19% | 1.62M | +4,010 | +0.25% | 2025-09-30 |
| Geode Capital Management, Llc | $3,997.00 | 1.94% | 1.43M | +49,673 | +3.59% | 2025-09-30 |
| Nuveen, Llc | $3,651.00 | 1.77% | 1.31M | -988,672 | -43.04% | 2025-09-30 |
| State Street Corp | $3,082.00 | 1.49% | 1.1M | +15,851 | +1.46% | 2025-09-30 |